CERO THERAPEUTICS HOLDINGS, INC. Cash
CERO THERAPEUTICS HOLDINGS, INC. (CERO) had Cash of $937.51 billion as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:Cash · last filed 2026-08-14
- 2026-06-30: Cash $937.51B.
- 2026-03-31: Cash $857.49B.
- 2025-12-31: Cash $1.70M.
- 2025-09-30: Cash $1.88M.
| Period end | Cash |
|---|---|
| 2026-06-30 | $937.51B 10-Q · filed 2026-08-14 |
| 2026-03-31 | $857.49B 10-Q · filed 2026-05-15 |
| 2025-12-31 | $1.70M 10-K · filed 2026-04-15 |
| 2025-09-30 | $1.88M 10-Q · filed 2025-11-19 |
| 2025-06-30 | $1.88M 10-Q · filed 2025-08-22 |
| 2025-03-31 | $1.88M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $1.88M 10-K · filed 2025-04-15 |
| 2024-09-30 | $963.86K 10-Q/A · filed 2024-11-20 |
| 2024-06-30 | $963.86K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $963.86M 10-Q · filed 2024-05-17 |
| 2023-12-31 | $96.87K 10-K · filed 2024-04-02 |
| 2023-09-30 | $119.01K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $105.23K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $178.09K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $475.87K 10-K · filed 2024-04-02 |
| 2022-09-30 | $507.92K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $553.77K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $790.48K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $1.10M 10-K · filed 2023-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |